An analysis of step-like field defects in Gilles de la Tourette syndrome

References

• Leckman J. F., Cohen D. J. Descriptive and diagnostic classification of tic disorders. Tourette's Syndrome and Tic Disorders. Clinical Understanding and Treatment, D. J. Cohen, R. D. Bruun, J. F. Leckman. John Wiley & Sons, New York 1988; 3–20
   Google Scholar
• Shapiro A. K., Shapiro E. S., Young J. G., Feinberg T. E. Neurology. Gilles de la Tourette Syndrome, A. K. Shapiro, E. S. Shapiro, J. G. Young, T. E. Feinberg. Raven Press, New York 1988; 285
   Google Scholar
• Shapiro A. K., Shapiro E. S., Young J. G., Feinberg T. E. Signs, symptoms and clinical course. Gilles de la Tourette Syndrome, A. K. Shapiro, E. S. Shapiro, J. G. Young, T. E. Feinberg. Raven Press, New York 1988; 127–194
   Google Scholar
• Enoch J. M., Itzhaki A., Lakshminarayanan V., Comerford J. P., Lieberman M., Lowe T. Gilles de la Tourette syndrome Visual effect. Neuro-Ophthalmology 1988; 8: 251–257
   Web of Science ®Google Scholar
• Enoch J. M., Itzhaki A., Lakshminarayanan V., Comerford J. P., Lieberman M. Visual field defects detected in patients with Gilles de la Tourette syndrome: preliminary report. Int Ophthalmol 1989; 13: 331–344
   PubMed Web of Science ®Google Scholar
• Reed H. Essentials of Perimetry. Oxford University Press, London 1962
   Google Scholar
• Drance S. M. The glaucomatous visual field. Br J Ophthalmol 1972; 56: 186–200
   PubMed Web of Science ®Google Scholar
• Brais P., Drance S. M. The temporal field in chronic simple glaucoma. Arch Ophthalmol 1972; 88: 518–522
   PubMedGoogle Scholar
• Enoch J. M., Lawrence B. A perimetric technique believed to test receptive field properties: Sequential evaluation in glaucoma and other conditions. Am J Ophthalmol 1975; 80: 734–758
   PubMedGoogle Scholar
• Enoch J. M., Fitzgerald C. R., Campos E. C. Quantitative Layer by Layer Perimetry An Extended Analysis. Grune & Stratton, New York 1981
   Google Scholar
• Kolker A. E. Visual prognosis in advanced glaucoma. Glaucoma, J. E. Cairns. Grune & Stratton, London 1986; Vol II: pp 647–660
   Google Scholar
• Phelps C. D., Hayreh S. S., Montague P. R. Visual fields in low tension glaucoma, primary open angle glaucoma and anterior ischaemic optic neuropathy. Docum Ophthalmol Proc Series 1983; 35: 113–129
   Google Scholar
• Hayreh S. S., Podhajsky P. Visual field defects in anterior ischaemic optic neuropathy. Docum Ophthalmol Proc Series 1979; 19: 53–71
   Google Scholar
• Enoch J. M., Essock E. A., Williams R. A., Barricks M. Functional visual effect of lesions located near the optic nerve head. Docum Ophthalmol Proc Series 1984; 61: 131–156
   Google Scholar
• Hoyt W. F. Personal communication 1989
   Google Scholar
• Moses R. Personal communication 1989
   Google Scholar
• Aulhorn E. Visual field defects in chronic glaucoma. Glaucoma - Conception of a Disease, K. Heilman, K. T. Richardson. WB Saunders Co, Philadelphia 1978; 157–167
   Google Scholar
• Kolker A. E., Hetherington J., Jr. Peripheral and central fields. Becker-Shaffer's Diagnosis and Therapy of Glaucomas. CV Mosby Co, St Louis 1983
   Google Scholar
• Ehinger B. Neurotransmitter systems in the retina. Retina 1982; 2: 305–321
   PubMed Web of Science ®Google Scholar
• Dowling J. E., Ehinger B. Synaptic organization of the amine containing interplexiform cells of the gold fish and cebus monkey retina. Science 1975; 188: 270–273
   PubMed Web of Science ®Google Scholar
• Masland R. H. The functional architecture of the retina. Sci Am 1986; 255: 102–111
   PubMedGoogle Scholar
• Frederick J. M., Rayborn M. E., Laties A. M., Lam D. M.K., Hollyfield J. G. Dopaminergic neurons in the human retina. J Comp Neurol 1982; 210: 65–79
   PubMed Web of Science ®Google Scholar
• Mariani A. P., Mokoc J. M. Two types of tyrosine hydroxylase-immunoreactive amacrine cell in the rhesus monkey retina. J Comp Neurol 1988; 276: 81–91
   PubMedGoogle Scholar
• Zarbin M. A., Wamsley J. K., Palacios J. M., Kuhar M. J. Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina. Brain Res 1986; 374: 75–92
   PubMed Web of Science ®Google Scholar
• Enoch J. M., Savage G. L., Lakshminarayanan V. Anomalous visual response in Tourette's syndrome. Docum Ophthalmol Proc Series 1987; 49: 667–672
   Google Scholar
• Enoch J. M., Lakshminarayanan V., Itzhaki A. Psychophysical studies of neuropsychiatric patients on and off haloperidol. Dopaminergic Mechanisms in Vision, I. Bodis-Wollner, M. Piccolino. Alan R Liss, New York 1988; 227–237
   Google Scholar
• Khamar B. M., Enoch J. M., Lowe T. L., Schrier H. Temporal steps in the visual field in neuropsychiatric disorders. Lancet 1989; 2(8674): 1283–1284
   Google Scholar
• Versaux-Botteri C., Martin-Martinelli E., Hguyen-Legros J., Geffard M., Vigny A., Denoroy L. Regional specialization of the rat retina: Catecholamine-containing amacrine cell characterization and distribution. J Comp Neurol 1986; 243: 442–453
   Google Scholar
• Mariani A. P., Kolb H., Nelson R. Dopamine-containing amacrine cells of rhesus monkey retina parallel rods in spatial distribution. Brain Res 1984; 322: 1–7
   PubMedGoogle Scholar
• Barnett A. Dopamine receptors and behavior. Neurotransmitters, Receptors and Drug Action, W. B. Essman. Spectrum Publications Inc, New York 1980; 69
   Google Scholar
• Ikeda H., Priest T. D., Robins J., Wakakuwa K. Silent dopaminergic synapse at feline retinal ganglion cells. Clin Vis Sci 1986; 1: 25–38
   Google Scholar
• Kamp C. W. Dopamine system of the retina. Retinal Transmitters and Modulators. Models for the Brain, W. W. Morgan. CRC Press, Boca Raton 1984; 10
   Google Scholar
• Starr M. S. The effects of various amino acids, dopamine and some convulsants on the electroretinogram of the rabbit. Exp Eye Res 1975; 21: 79–87
   PubMedGoogle Scholar
• Jagadeesh J. M., Sanchez R. Effects of apomorphine on the rabbit electroretinogram. Invest Ophthalmol Vis Sci 1981; 21: 620–625
   PubMed Web of Science ®Google Scholar
• Enoch J. M., Khamar B. M., Lakshminarayanan V. Static and kinetic perimetric field defects in Gilles de la Tourette syndrome : Quantifying step-like visual field defects. Clin Vis Sci submitted
   Google Scholar
• Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol 1983; 40: 508–514
   Google Scholar
• Sandyk R. Alpha melanocyte stimulating hormone (MSH) in Tourette's syndrome. Int J Neurosci 1989; 44: 161–164
   PubMed Web of Science ®Google Scholar
• Sandyk R. Dopaminergic supersensitivity factors in Tourette's syndrome: A hypothesis. Int J Neurosci 1989; 44: 169–174
   PubMed Web of Science ®Google Scholar
• Leckman J. F., Riddle M. A., Cohen D. J. Pathobiology of Tourette's syndrome. Tourette's Syndrome and Tic Disorders. Clinical Understanding and Treatment, D. J. Cohen, R. D. Bruun, J. F. Leckman. John Wiley & Sons, New York 1988; 103–118
   Google Scholar
• Lankford K. L., DeMello F. G., Klein W. L. A transient embryonic dopamine receptor inhibits growth cone motility and neu-rite outgrowth in a subset of avian retina neurons. Neurosci Lett 1987; 75: 169–174
   PubMedGoogle Scholar
• Lankford K. L., DeMello F. G., Klein W. L. D-1 type dopamine receptors inhibit growth cone motility in cultured retina neurons : Evidence that neurotransmitters act as morphogenic growth regulators in developing the central nervous system. Proc Natl Acad Sci USA 1988; 85: 4567–4571
   PubMed Web of Science ®Google Scholar
• McCobb D. P., Haydon P. G., Kater S. B. Dopamine and serotonin inhibition of neurite elongation of different identified neurons. J Neurosci Res 1988; 19: 19–26
   PubMed Web of Science ®Google Scholar
• McCobb D. P., Kater S. B. Membrane voltage and neurotransmitter regulation of neuronal growth cone motility. Devel Biol 1988; 130: 599–609
   PubMedGoogle Scholar
• Leckman J. F., Cohen D. J., Gertner J. M., Ort S., Harcherik M. J. Growth hormone response to clonidine in children aged 4-17: Tourette's syndrome vs. children with short stature. J Am Acad Child Psychiat 1984; 23: 174–181
   PubMedGoogle Scholar
• Sandyk R., Bamford C. R. Opioid modulation of gonadotrophin release in Tourette's syndrome. Int J Neurosci 1988; 39: 233–234
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Lacono R. P., Crinnian C. T. Abnormal growth hormone response to naloxone challenge in Tourette's syndrome. Int J Neurosci 1987; 37: 191–192
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Binkiewicz A., Finley P. R. Gonadotrophin deficiency in Tourette's syndrome: A preliminary communication. Int J Neurosci 1988; 42: 121–125
   PubMed Web of Science ®Google Scholar
• Young J. G., Cohen D. J., Mattox S. E., Kavanagh B. S. Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's syndrome: Preliminary report. Life Sci 1981; 29: 1467–1475
   PubMed Web of Science ®Google Scholar